30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Ron Sugar

Track

Insider profile

Currently holds positions in Uber Technologies Inc, Amgen Inc, Apple Inc and Chevron Corp

Positions

Position Company Period
Independent Chairperson of the Board Uber Technologies Inc July 1, 2018 -
Independent Director Amgen Inc July 22, 2010 -
Independent Director Apple Inc Nov. 17, 2010 -
Lead Independent Director Chevron Corp Jan. 1, 2015 -
Independent Director Air Lease Corp April 1, 2010 - May 1, 2020
Independent Director Chevron Corp April 27, 2005 - Jan. 1, 2015
Ron Sugar's trades of Amgen Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-05-12 2021-05-12
US Amgen Inc (AMGN)
PlS Planned sale
29,141 +4.3%
93.27
US$4,281,482 		29,141 +4.3% 93.27 US$4,281,482
2021-04-15 2021-04-14
US Amgen Inc (AMGN)
PlS Planned sale
48,122 -2.3%
58.68
US$1,082,053 		48,122 -2.3% 58.68 US$1,082,053
2021-03-10 2021-03-10
US Amgen Inc (AMGN)
PlS Planned sale
62,928 +1.9%
402.99
US$4,681,426 		62,928 +1.9% 402.99 US$4,681,426
2021-02-10 2021-02-10
US Amgen Inc (AMGN)
PlS Planned sale
1,000 -6.0%
238.40
US$238,400 		1,000 -6.0% 238.40 US$238,400
2021-01-14 2021-01-13
US Amgen Inc (AMGN)
PlS Planned sale
1,000 -6.0%
235.99
US$235,990 		1,000 -6.0% 235.99 US$235,990
2020-08-19 2020-08-19
US Amgen Inc (AMGN)
PlS Planned sale
1,000 -6.0%
241.02
US$241,020 		1,000 -6.0% 241.02 US$241,020
2020-07-22 2020-07-22
US Amgen Inc (AMGN)
PlS Planned sale
1,000 -6.0%
259.79
US$259,790 		1,000 -6.0% 259.79 US$259,790
2020-06-17 2020-06-17
US Amgen Inc (AMGN)
PlS Planned sale
1,000 -6.0%
228.54
US$228,540 		1,000 -6.0% 228.54 US$228,540
2020-05-20 2020-05-20
US Amgen Inc (AMGN)
PlS Planned sale
1,000 -6.1%
229.27
US$229,270 		1,000 -6.1% 229.27 US$229,270
2020-04-22 2020-04-22
US Amgen Inc (AMGN)
PlS Planned sale
1,000 -6.4%
233.35
US$233,350 		1,000 -6.4% 233.35 US$233,350
2019-11-07 2019-11-06
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -12.2%
215.45
US$430,900 		2,000 -12.2% 215.45 US$430,900
2019-10-03 2019-10-02
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -12.2%
193.58
US$387,160 		2,000 -12.2% 193.58 US$387,160
2019-09-04 2019-09-04
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -12.2%
206.70
US$413,400 		2,000 -12.2% 206.70 US$413,400
2019-08-08 2019-08-07
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -12.2%
183.04
US$366,080 		2,000 -12.2% 183.04 US$366,080
2019-07-08 2019-07-03
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -12.2%
187.58
US$375,160 		2,000 -12.2% 187.58 US$375,160
2019-06-05 2019-06-05
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -12.3%
175.68
US$351,360 		2,000 -12.3% 175.68 US$351,360
2019-05-03 2019-05-01
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -13.3%
175.73
US$351,460 		2,000 -13.3% 175.73 US$351,460
2019-04-03 2019-04-03
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -13.3%
193.18
US$386,360 		2,000 -13.3% 193.18 US$386,360
2019-03-08 2019-03-06
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -13.3%
188.88
US$377,760 		2,000 -13.3% 188.88 US$377,760
2019-02-11 2019-02-07
US Amgen Inc (AMGN)
PlS Planned sale
2,000 -13.3%
190.00
US$380,000 		2,000 -13.3% 190.00 US$380,000